Partners

The TB Vaccine Development Pathway was established by a team of scientific and technical experts from TBVI and Aeras with the input of the TB vaccine community. The tool has been developed on behalf of the Global TB Vaccine Partnership (GTBVP), an alliance of organisations that aim at making novel TB vaccines a reality, and is funded by the Bill & Melinda Gates Foundation.

The GTBVP is an alliance of organisations that aim at making novel TB vaccines a reality. Current members are:

Observers:

World Health Organization (WHO)

National Institutes of Health (NIH)